Firms

Sanderling Ventures

Sanderling Ventures

sanderling.com

Sanderling Ventures is a biomedical venture capital firm that finances and helps build early-stage life-sciences companies. It combines seed and venture investment with hands-on company management, scientific and regulatory support, operational leadership and later financing. Its investments span drug development, medical technology and digital health, including rare-disease developer Glycomine. Founded in 1979, Sanderling works with entrepreneurs from company formation through clinical and commercial development and has backed more than 90 biomedical companies. Its published roster includes investment managers, venture partners, legal counsel and an emeritus managing director, alongside a memorial to late founding partner Robert G. McNeil.

Founded
1979
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Benjamin F. McGraw IIIVenture Partner
Fred MiddletonManaging Director
Michael DixonPrincipal
Paulette TaylorOf Counsel, General Counsel and Principal
Peter McWilliamsVenture Partner
Pierre BeauparlantVenture Partner
Timothy C. MillsManaging Director and Investment Committee Chair
Timothy WollaegerManaging Director Emeritus

Co-investing

Chiesi Ventures
Novo Holdings
Abingworth LLP
Remiges Ventures
RiverVest Venture Partners

Investments